Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

GSK

Gsk (GSK)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK
DataOraFonteTitoloSimboloCompagnia
12/06/202416:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/06/202410:32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
11/06/202408:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
10/06/202420:00Alliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
10/06/202409:39Alliance NewsAlliance NewsGSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSVLSE:GSKGsk Plc
10/06/202408:00RNS Regulatory NewsGSK PLC FDA approves Arexvy for adults 50-59 at riskLSE:GSKGsk Plc
03/06/202416:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
03/06/202415:01Alliance NewsAlliance NewsGSK immunotherapy bowel cancer drug works for 100% of patientsLSE:GSKGsk Plc
03/06/202414:03RNS Regulatory NewsGSK PLC Unprecedented results in Jemperli trial continueLSE:GSKGsk Plc
03/06/202410:08Alliance NewsAlliance NewsTOP NEWS: GSK vows to appeal adverse Delaware court ruling on ZantacLSE:GSKGsk Plc
03/06/202408:05RNS Regulatory NewsGSK PLC ASCO positive Blenrep DREAMM-8 trial resultsLSE:GSKGsk Plc
24/05/202409:36Alliance NewsAlliance NewsTOP NEWS: GSK celebrates Illinois jury verdict in Valadez caseLSE:GSKGsk Plc
21/05/202409:49Alliance NewsAlliance NewsGSK's depemokimab asthma treatment meets endpoints in latest trialsLSE:GSKGsk Plc
21/05/202408:00RNS Regulatory NewsGSK PLC Positive phase III asthma results for depemokimabLSE:GSKGsk Plc
20/05/202417:11Alliance NewsAlliance NewsIN BRIEF: GSK executive buys GBP20,026 worth sharesLSE:GSKGsk Plc
17/05/202410:03Alliance NewsAlliance NewsTOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billionLSE:GSKGsk Plc
17/05/202408:00RNS Regulatory NewsGSK PLC GSK completes sale of shares in Haleon plcLSE:GSKGsk Plc
16/05/202418:13Alliance NewsAlliance NewsTOP NEWS: GSK to sell remaining holding in spin-off HaleonLSE:GSKGsk Plc
16/05/202417:42RNS Regulatory NewsGSK PLC GSK announces intention to sell shares in HaleonLSE:GSKGsk Plc
13/05/202416:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
08/05/202419:21RNS Regulatory NewsGSK PLC Result of AGMLSE:GSKGsk Plc
08/05/202417:57RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
01/05/202409:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202408:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202410:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202408:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202409:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202408:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202408:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202415:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network